摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-dichloro-7-[(2S,4R,5S)-4-(4-methylphenoxy)-5-[(4-methylphenoxy)methyl]tetrahydrofuran-2-yl]purine

中文名称
——
中文别名
——
英文名称
2,6-dichloro-7-[(2S,4R,5S)-4-(4-methylphenoxy)-5-[(4-methylphenoxy)methyl]tetrahydrofuran-2-yl]purine
英文别名
2,6-dichloro-7-[(2S,4R,5S)-4-(4-methylphenoxy)-5-[(4-methylphenoxy)methyl]oxolan-2-yl]purine
2,6-dichloro-7-[(2S,4R,5S)-4-(4-methylphenoxy)-5-[(4-methylphenoxy)methyl]tetrahydrofuran-2-yl]purine化学式
CAS
——
化学式
C24H22Cl2N4O3
mdl
——
分子量
485.37
InChiKey
BVFHGAPJCPMNRY-AABGKKOBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.2
  • 重原子数:
    33
  • 可旋转键数:
    6
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    71.3
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    2-deoxy-3,5-di-O-(p-toluoyl)-α-D-erythro-pentofuranosyl chloride2,6-二氯嘌呤 在 sodium hydride 作用下, 生成 2,6-dichloro-7-[(2S,4R,5S)-4-(4-methylphenoxy)-5-[(4-methylphenoxy)methyl]tetrahydrofuran-2-yl]purine 、 2,6-dichloro-9-[3',5'-di-O-(4-methylbenzoyl)-2'-deoxy-β-D-ribofuranosyl]purine 、 2,6-dichloro-9-[(2S,4S,5R)-4-(4-methylphenoxy)-5-[(4-methylphenoxy)methyl]oxolan-2-yl]purine
    参考文献:
    名称:
    Sodium salt glycosylation in the synthesis of purine 2'-deoxyribonucleosides: studies of isomer distribution
    摘要:
    A systematic study of 2-deoxyribonucleoside isomer distribution from the sodium salt glycosylation of substituted purines is reported. Reactions of 1-alpha-chloro-2-deoxy-3,5-di(p-toluyl)-erythro-pentofuranose with the sodium salts of purines in acetonitrile typically results in 9-beta and 7-beta regioisomers as major products in a ratio of about 4:1, results consistent with a S(N)2 reaction of base anion with the 1-alpha chlorosugar. However, the reaction with 2,6-dibromopurine (2) gave 9-beta and 9-alpha stereoisomers as major products in a 4:1 ratio. We have isolated and identified all nucleoside products from sodium salt glycosylations of several 2,6-disubstituted purines and 6-substituted purines. In addition to the major products, the 9-alpha and 7-alpha isomers were obtained in small yields in most cases. Rate studies showed that fastest glycosylations occurred with 2,6-bis(methylthio)purine (3). Glycosylations of 2,6-dichloropurine (1) and of 2 proceeded with nearly identical rates for the formation of the 9-beta isomers and with comparable rates for the formation of 7-beta and 9-alpha isomers, respectively. These observations indicate that the extent of sugar anomerization during glycosylation of 2 does not alone account for 9-alpha isomer formation, although, in a separate experiment, aging of chlorosugar solutions did increase the yield of 9-alpha product in the reaction. Studies of possible interconversion of isomers under the reaction conditions indicated that formation of the 9-alpha isomer from 2 was not the result of conversion of a kinetically favored (7-beta) isomer, nor was the 7-beta isomer from 1 derived from conversion of the 9-alpha isomer. We conclude that a combination of steric effect of the 6-bromo group and an as yet unidentified rate effect of the 2-bromo group is responsible for the significant yield of 9-alpha product from 2. The ability of substituents to enhance the rate and regioselectivity in the sodium salt glycosylation was evaluated with 2-bromo-6-(methylthio)purine (6). This base afforded the highest total nucleoside yield (86%) and the highest 9-beta isomer yield (68.3%) among all purines tested, suggesting a useful strategy to increase yield of intermediates that can be converted to biologically important purine 2'-deoxy-ribonucleosides.
    DOI:
    10.1021/jo00032a038
点击查看最新优质反应信息

文献信息

  • Sodium salt glycosylation in the synthesis of purine 2'-deoxyribonucleosides: studies of isomer distribution
    作者:Catherine Hildebrand、George E. Wright
    DOI:10.1021/jo00032a038
    日期:1992.3
    A systematic study of 2-deoxyribonucleoside isomer distribution from the sodium salt glycosylation of substituted purines is reported. Reactions of 1-alpha-chloro-2-deoxy-3,5-di(p-toluyl)-erythro-pentofuranose with the sodium salts of purines in acetonitrile typically results in 9-beta and 7-beta regioisomers as major products in a ratio of about 4:1, results consistent with a S(N)2 reaction of base anion with the 1-alpha chlorosugar. However, the reaction with 2,6-dibromopurine (2) gave 9-beta and 9-alpha stereoisomers as major products in a 4:1 ratio. We have isolated and identified all nucleoside products from sodium salt glycosylations of several 2,6-disubstituted purines and 6-substituted purines. In addition to the major products, the 9-alpha and 7-alpha isomers were obtained in small yields in most cases. Rate studies showed that fastest glycosylations occurred with 2,6-bis(methylthio)purine (3). Glycosylations of 2,6-dichloropurine (1) and of 2 proceeded with nearly identical rates for the formation of the 9-beta isomers and with comparable rates for the formation of 7-beta and 9-alpha isomers, respectively. These observations indicate that the extent of sugar anomerization during glycosylation of 2 does not alone account for 9-alpha isomer formation, although, in a separate experiment, aging of chlorosugar solutions did increase the yield of 9-alpha product in the reaction. Studies of possible interconversion of isomers under the reaction conditions indicated that formation of the 9-alpha isomer from 2 was not the result of conversion of a kinetically favored (7-beta) isomer, nor was the 7-beta isomer from 1 derived from conversion of the 9-alpha isomer. We conclude that a combination of steric effect of the 6-bromo group and an as yet unidentified rate effect of the 2-bromo group is responsible for the significant yield of 9-alpha product from 2. The ability of substituents to enhance the rate and regioselectivity in the sodium salt glycosylation was evaluated with 2-bromo-6-(methylthio)purine (6). This base afforded the highest total nucleoside yield (86%) and the highest 9-beta isomer yield (68.3%) among all purines tested, suggesting a useful strategy to increase yield of intermediates that can be converted to biologically important purine 2'-deoxy-ribonucleosides.
查看更多

同类化合物

顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 阿巴卡韦羧酸盐 阿巴卡韦相关物质D 阿巴卡韦杂质F 阿巴卡韦杂质 阿巴卡韦中间体A5 阿巴卡韦5’-磷酸酯 阿巴卡韦,拉米夫定混合物 阿巴卡韦 芒霉素 艾夫他滨 腺苷基(3'-5')胞苷基(3'-5')胞苷游离酸 脱氧假尿苷 胸苷酰-(5'-3')-胸苷酰-(5'-3')-胸苷酰-(5'-3')-5'-胸苷酸 胰腺癌RX-3117 硫酸阿巴卡韦 甲基磷羧酸氢[(2S,5R)-5-(4-氨基-2-羰基嘧啶-1(2H)-基)-2,5-二氢呋喃-2-基]甲酯 瓶型酵母D 瓶型酵母A 环戊烯基尿嘧啶 水杨酸拉米呋啶 氟达拉滨EP杂质H 曲沙他滨 拉米夫定相关化合物(Α-TROXACITABINE) 拉米夫定杂质Ⅲ1-[(2R,5S)-2-羟甲基-1,3-氧硫杂环戊-5-基]-嘧啶-2,4(1H,3H)-酮 拉米夫定杂质1 拉米夫定S-氧化物(异构体混合物) 拉米夫定 拉米夫定 拉夫米定EP杂质J 拉夫米定EP杂质H 扎西他宾 恩替卡韦相关物质A 恩替卡韦一水合物 恩曲他滨杂质16 恩曲他滨S-氧化物 恩曲他滨 恩曲他滨 怀俄苷三乙酸酯 怀俄苷 己二酸,聚合1,2-丁二醇 外消旋拉米夫定酸 吡唑霉素 司他夫定 反式-阿巴卡韦盐酸盐 卡波啶 卡巴韦